These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17506366)

  • 1. Use of progesterone to prevent preterm birth at a tertiary care center.
    Bailit JL; Berkowitz R; Thorp JM; Cleary K; Hartmann KE; Mercer BM
    J Reprod Med; 2007 Apr; 52(4):280-4. PubMed ID: 17506366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes and practices regarding use of progesterone to prevent preterm births.
    Henderson ZT; Power ML; Berghella V; Lackritz EM; Schulkin J
    Am J Perinatol; 2009 Aug; 26(7):529-36. PubMed ID: 19301227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone for preterm birth prevention: an evolving intervention.
    Tita AT; Rouse DJ
    Am J Obstet Gynecol; 2009 Mar; 200(3):219-24. PubMed ID: 19254577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of preterm delivery with gestagens].
    Schindler AE
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):165-9. PubMed ID: 15508049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progesterone for prevention of preterm delivery: only in trial setting].
    Lim AC; Mol BW; Bruinse HW
    Ned Tijdschr Geneeskd; 2010; 154():A1730. PubMed ID: 20858311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?
    Hall NR
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):235-46, ix-x. PubMed ID: 21575799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of clinician and patient attitudes towards the use of progesterone for women at risk of preterm birth.
    Dodd JM; Ashwood P; Flenady V; Jenkins-Manning S; Cincotta R; Crowther CA
    Aust N Z J Obstet Gynaecol; 2007 Apr; 47(2):106-9. PubMed ID: 17355298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of progesterone treatment for the prevention of recurrent preterm birth: identification of obstacles to change.
    Lim AC; Goossens A; Ravelli AC; Boer K; Bruinse HW; Mol BW
    Am J Perinatol; 2010 Mar; 27(3):241-9. PubMed ID: 19823963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone for preventing premature birth: practice patterns of board-certified maternal-fetal medicine specialists in the United States.
    Ness A; Baxter J; Hyslop T; Berghella V
    J Reprod Med; 2006 May; 51(5):411-5. PubMed ID: 16779989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Meis PJ; Klebanoff M; Dombrowski MP; Sibai BM; Leindecker S; Moawad AH; Northen A; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Miodovnik M; Leveno KJ; Conway D; Wapner RJ; Carpenter M; Mercer B; Ramin SM; Thorp JM; Peaceman AM; Gabbe S
    Obstet Gynecol; 2005 Sep; 106(3):557-61. PubMed ID: 16135587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice variation in the use of interventions in high-risk obstetrics.
    Bronstein JM; Cliver SP; Goldenberg RL
    Health Serv Res; 1998 Feb; 32(6):825-39. PubMed ID: 9460488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstetric management of moderate and late preterm labour.
    McParland PC
    Semin Fetal Neonatal Med; 2012 Jun; 17(3):138-42. PubMed ID: 22410256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone.
    Maggio L; Rouse DJ
    Clin Obstet Gynecol; 2014 Sep; 57(3):547-56. PubMed ID: 24936913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17 hydroxyprogesterone for the prevention of preterm delivery.
    Meis PJ;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1128-35. PubMed ID: 15863556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal progesterone after tocolytic therapy in threatened preterm labor.
    Bomba-Opon DA; Kosinska-Kaczynska K; Kosinski P; Wegrzyn P; Kaczynski B; Wielgos M
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1156-9. PubMed ID: 21967664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction and prevention of recurrent spontaneous preterm birth.
    Spong CY
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):405-15. PubMed ID: 17666618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Born too soon: the continuing challenge of preterm labor and birth in the United States.
    Reedy NJ
    J Midwifery Womens Health; 2007; 52(3):281-90. PubMed ID: 17467595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From concept to practice: the recent history of preterm delivery prevention. Part II: Subclinical infection and hormonal effects.
    Vidaeff AC; Ramin SM
    Am J Perinatol; 2006 Feb; 23(2):75-84. PubMed ID: 16506112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late preterm birth: how often is it avoidable?
    Holland MG; Refuerzo JS; Ramin SM; Saade GR; Blackwell SC
    Am J Obstet Gynecol; 2009 Oct; 201(4):404.e1-4. PubMed ID: 19716546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.